Treatment Guidelines

August 27, 2022

Our cardiology month in review spotlights the most popular content from the past month. The top content from August 2022 includes new antithrombotic guidance from CHEST, USPSTF recommendation statement on statin use in primary prevention, and coverage of ESC 22, including DELIVER, TIME, and other late-breaking data.

August 23, 2022

The USPSTF released a new recommendation statement on August 23 outlining the organization's stance on use of statins for primary prevention based on current available evidence, with recommendations made for those 40-75, 75 and older, and based on 10-year CVD risk.

July 26, 2022

On July 26, the US Preventive Services Task Force released an updated recommendation statement outlining the organization's stance on behavioral counseling aimed at improving diet and physical activity in adults without cardiovascular risk factors, which was awarded a level C recommendation and is consistent with their 2017 recommendations on the topic.

May 28, 2022

Our cardiology month in review spotlights the most popular content from the past month. This month's top articles include news from DELIVER, new guidelines for ICH and PFO, and a juxtaposition of international heart failure guidelines.

May 17, 2022

Published on May 17, the 2022 AHA/ASA guidelines for the management of intracerebral hemorrhage were created with the intent of replacing 2015 guidance with updated evidence-based recommendations.

May 04, 2022

In this episode of Don't Miss a Beat, hosts Drs. Greene and Vaduganathan break down the new ACC/AHA/HFSA heart failure guidelines debuted at ACC.22 and compare the recommendations against those made in the European Society of Cardiology's 2021 heart failure guidelines.

April 26, 2022

Published in JAMA on April 26, the latest recommendation statement from the USPSTF gives a grade C recommendation for use of low-dose aspirin for primary prevention of cardiovascular disease in adults aged 40-59 years who have a 10% or greater 10-year cardiovascular disease risk, concluding it could provide a small net benefit in these patients.

April 23, 2022

Our cardiology month in review spotlights the most popular articles from the past month. This month's top articles include new heart failure guidelines, data from ACC.22, and more!

April 14, 2022

The latest scientific statement from the American Heart Association is aimed at improving the awareness of NAFLD and its associated cardiovascular risk among clinicians as well as optimizing diagnosis and early treatment strategies for patients with NAFLD.

April 02, 2022

Muthiah Vaduganathan, MD, MPH, discusses new recommendations in the heart failure guidelines released at ACC.22 and provides perspective on the historic significance of the guideline.